|
Volumn 51, Issue 3, 2002, Pages 211-218
|
Curcumin enhances cytotoxicity of chemotherapeutic agents in prostate cancer cells by inducing p21WAF1/CIP1 and C/EBPβ expressions and suppressing NF-κB activation
|
Author keywords
Cell cycle; Drug administration schedule; Drug synergism; Drug therapy; Protein p53
|
Indexed keywords
CURCUMIN;
DOXORUBICIN;
FLUOROURACIL;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
PACLITAXEL;
PROTEIN P21;
PROTEIN P53;
ANIMAL CELL;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CANCER COMBINATION CHEMOTHERAPY;
CELL CYCLE;
CYTOTOXICITY;
DRUG EFFECT;
DRUG POTENTIATION;
NONHUMAN;
PRIORITY JOURNAL;
PROSTATE CANCER;
TRANSCRIPTION INITIATION;
ANTINEOPLASTIC AGENTS;
CCAAT-ENHANCER-BINDING PROTEIN-BETA;
CELL CYCLE;
CELL NUCLEUS;
CURCUMIN;
CYCLIN-DEPENDENT KINASE INHIBITOR P21;
CYCLINS;
DNA;
DRUG SYNERGISM;
HUMANS;
MALE;
NF-KAPPA B;
PREGNANCY-SPECIFIC BETA 1-GLYCOPROTEINS;
PROSTATIC NEOPLASMS;
SP1 TRANSCRIPTION FACTOR;
TUMOR CELLS, CULTURED;
UP-REGULATION;
|
EID: 0037093926
PISSN: 02704137
EISSN: None
Source Type: Journal
DOI: 10.1002/pros.10089 Document Type: Article |
Times cited : (126)
|
References (28)
|